cuprizone has been researched along with Autoimmune Demyelinating Diseases, Central Nervous System in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bullitta, S; Buttari, F; Centonze, D; De Vito, F; Fresegna, D; Gentile, A; Guadalupi, L; Mandolesi, G; Musella, A; Rizzo, FR; Stampanoni Bassi, M; Vanni, V; Viscomi, MT | 1 |
Doi, T; Hamanoue, M; Hayakawa, K; Imamura, O; Morioka, K; Nagao, M; Ogata, T; Okazaki, R; Sawada, Y; Takishima, K; Tanaka, S | 1 |
Bernard, F; Chédotal, A; Franklin, RJ; Hu, B; Ji, B; Jung, V; Lee, X; Mason, J; Mi, S; Miklasz, S; Miller, RH; Pepinsky, B; Roulois, A; Shao, Z; Shea, D; Shields, CB; Tang, W; Wu, W; Xu, J; Zhang, Y | 1 |
Barnum, SR; Briggs, DT; Ingersoll, SA; Martin, BK; Martin, CB | 1 |
Cook, DN; Matsushima, GK; McMahon, EJ; Suzuki, K | 1 |
5 other study(ies) available for cuprizone and Autoimmune Demyelinating Diseases, Central Nervous System
Article | Year |
---|---|
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination.
Topics: Animals; Brain; Cuprizone; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Physical Conditioning, Animal | 2019 |
The crucial role of Erk2 in demyelinating inflammation in the central nervous system.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cuprizone; Cytokines; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Embryo, Mammalian; Enzyme Activation; Female; Gene Expression Regulation; Gliosis; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Monoamine Oxidase Inhibitors; Motor Disorders; Myelin Basic Protein; Nestin; Neuroglia; Neurons; Rats; Rats, Wistar | 2016 |
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
Topics: Animals; Animals, Newborn; Antibodies; Cell Differentiation; Cells, Cultured; Cuprizone; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Ganglia, Spinal; Lysophosphatidylcholines; Membrane Proteins; Mice; Myelin Proteins; Myelin Sheath; Nerve Tissue Proteins; Oligodendroglia; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Stem Cells | 2009 |
Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
Topics: Animals; Apoptosis; Astrocytes; Brain; Chelating Agents; Complement System Proteins; Corpus Callosum; Cuprizone; Cytoprotection; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Glial Fibrillary Acidic Protein; Gliosis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nerve Regeneration; Oligodendroglia; Receptors, Complement; Receptors, Complement 3b; Time Factors | 2007 |
Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier.
Topics: Animals; Astrocytes; Blood-Brain Barrier; Chemokine CCL3; Chemokine CCL4; Chemokine CCL5; Chemokines; Cuprizone; Demyelinating Autoimmune Diseases, CNS; Macrophage Inflammatory Proteins; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Receptors, Chemokine; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |